Farms.com Home   News

Poultry Sales, Exhibits Temporarily Banned Due To Bird Flu

Poultry Sales, Exhibits Temporarily Banned Due To Bird Flu

Minnesota animal health officials are imposing a ban on all poultry sales and exhibitions through the month of April after the presence of bird flu was found in the state.

The ban, which includes poultry community sales, swaps, fairs, exhibitions and other events where birds are brought together, is effective Friday and lasts through May 1.

A report from the Minnesota Board of Animal Health says avian influenza has been found in commercial flocks in Meeker, Stearns, Kandiyohi and Lac Qui Parle counties and in a backyard producer in Mower County.

“Viruses like HPAI need hosts to continue to spread,” said state veterinarian, Dr. Beth Thompson. “It’s our job to stop the spread of disease. Unfortunately, in this situation we feel one of the best things we can do for the health of all birds in Minnesota is to take a pause on poultry events through May 1.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.